B

한독

002390KOSPI

61.8 / 100

Reference Date: 2026-09-08

Financial Score21.5 / 40
News Sentiment21.3 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Han Dong, established in 1954, operates in pharmaceuticals, medical devices, health functional foods, and real estate leasing. Key products include Amaryl, Tenelria, and RediQ, with headquarters in Seoul's Gangnam-gu, a factory in Yongcheon, Chungcheongbuk, and a research institute in Gangseo-gu, Seoul. The company operates across multiple business segments.

Number of Employees

951people

Average Salary

78.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 15.004.0Point
PBR
0.47Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-0.79Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
34.98Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲1.3% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲207.8% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -8.5% (improving, 3yr)

Detailed News Sentiment

10 totalPositive 10Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position5.0Point

52w mid range (52%)

Current 9,530Won52-week high 12,07052-week low 6,700
1-month return3.0Point

1m 0.32% (flat)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-08-20
  • Neutral반기보고서 (2026.06)2026-08-14
  • Neutral전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)2026-08-13